← Back to catalogue
LZI Carisoprodol Metabolite (Meprobamate) Enzyme Immunoassay
FDA 510(k)Class II (US FDA 510(k))
510(k) DEN170010
Identifiers
- 510(k) Number
- DEN170010 FDA 510(k)
- FDA Product Code
- QBK FDA 510(k)
Classification
- Device Class
- Class II FDA 510(k)
- Legislation / Framework
- 21 CFR Part 862.3590 FDA 510(k)
- Regulation Number
- 862.3590 FDA 510(k)
- Advisory Committee
- Clinical Toxicology FDA 510(k)
- FDA Decision
- DENG FDA 510(k)
LZI Carisoprodol Metabolite (Meprobamate) Enzyme Immunoassay by Lin-Zhi International, Inc. — Class II — FDA_510K — listed in FDA 510(k)
Authorization Coverage (1 country)
Regulatory Authorizations
United States Active
FDA_510K
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA 510(k) | United States | FDA_510K | DEN170010 | Class II | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Lin-Zhi International, Inc.
Sources (1)
- FDA 510(k) DEN170010 24 fields · synced Jun 18, 2026